The basal cell surface of an NHBE cell-ALI culture was treated with purified flagellin from Pseudomonas aeruginosa (InvivoGen, USA) at 10 and 100 ng/ml for 3 and 24 h. In the experiments with transforming growth factor beta (TGF-β), 10 ng/ml of TGF-β1 or TGF-β2 (R&D Systems, South Korea) were pretreated 1 h before 100 ng/ml flagellin treatment.
Nhbe cells
NHBE cells are primary normal human bronchial epithelial cells derived from healthy adult donors. They are suitable for in vitro studies of respiratory biology and pathology.
Lab products found in correlation
31 protocols using nhbe cells
Flagellin and TGF-β Modulation of Airway Epithelium
The basal cell surface of an NHBE cell-ALI culture was treated with purified flagellin from Pseudomonas aeruginosa (InvivoGen, USA) at 10 and 100 ng/ml for 3 and 24 h. In the experiments with transforming growth factor beta (TGF-β), 10 ng/ml of TGF-β1 or TGF-β2 (R&D Systems, South Korea) were pretreated 1 h before 100 ng/ml flagellin treatment.
NHBE Airway Epithelial Cell Culture
Propagation and Maintenance of Influenza Viruses
Isolation and Culture of Macrophages
Primary Human Airway Epithelial Cell Culture
Human iPSC-derived alveolar epithelial type 2 cells (iHAEpC2) were obtained from Cell Applications Inc and cultured in growth media (i536K-05, Cell Applications Inc) according to the manufacturer’s instructions. All the primary cells were used within early passages (5–6) to avoid any gradual disintegration of the airway epithelium with columnar epithelial structure and epithelial integrity.
Culturing Cell Lines and Generating Influenza Virus
MDCK and NHBE Cell Culture Protocol
Cell Culture Protocols for Respiratory Research
Cysteamine Enhances Mucin Production in NHBE Cells
Detailed Cell Culture Protocol for Virus Infection
NHBE cells (Lonza Biosciences, Greenwood, SC, USA) are primary human cells maintained at an air–liquid interface at 37 °C with 5% CO2. NHBE cells were seeded at 10,000 cells/cm2 on polycarbonate transwell inserts with a 0.4 µm pore size diameter (Costar, Sigma Aldrich, St. Louis, MO, USA) with bronchial epithelial basal medium (BEBM, Lonza) supplemented with 5 μg/mL insulin, 0.5 ng/mL hEGF, 0.5 μg/mL hydrocortisone, 0.5 μg/mL epinephrine, 50 μg/mL gentamycin, 50 μg/mL amphotericin B, 10 μg/mL transferrin, 6.5 ng/mL triiodothyronin, and 0.13 mg/mL bovine pituitary extract (all supplied by Lonza) to obtain bronchial epithelial growth medium (BEGM).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!